Review of Vertebral Augmentation: An Updated Meta-analysis of the Effectiveness
- PMID: 30276087
- PMCID: PMC6159665
- DOI: 10.14444/5036
Review of Vertebral Augmentation: An Updated Meta-analysis of the Effectiveness
Abstract
Background: To update vertebral augmentation literature by comparing outcomes between vertebroplasty (VP), balloon kyphoplasty (BKP), vertebral augmentation with implant (VAI), and nonsurgical management (NSM) for treating vertebral compression fractures (VCFs).
Methods: A PubMed literature search was conducted with keywords kyphoplasty, vertebroplasty, vertebral body stent, and vertebral augmentation AND implant for English-language articles from February 1, 2011, to November 22, 2016. Among the results, 25 met the inclusion criteria for the meta-analysis. Inclusion criteria were prospective comparative studies for mid-/lower-thoracic and lumbar VCFs enrolling at least 20 patients. Exclusion criteria included studies that were single arm, systematic reviews and meta-analyses, traumatic nonosteoporotic or cancer-related fractures, lack of clinical outcomes, or non-Level I and non-Level II studies. Standardized mean difference between baseline and end point for each outcome was calculated, and treatment groups were pooled using random effects meta-analysis.
Results: Visual analog scale pain reduction for BKP and VP was -4.05 and -3.88, respectively. VP was better than but not significantly different from NSM (-2.66), yet BKP showed significant improvement from both NSM and VAI (-2.77). The Oswestry Disability Index reduction for BKP showed a significant improvement over VAI (P < .001). There was no significant difference in changes between BKP and VP for anterior (P = .226) and posterior (P = .293) vertebral height restoration. There was no significant difference in subsequent fractures following BKP (32.7%; 95% confidence interval [CI]: 8.8%-56.6%) or VP (28.3%; 95% CI: 7.0%-49.7%) compared with NSM (15.9%; 95% CI: 5.2%-26.6%).
Conclusions/level of evidence: Based on Level I and II studies, BKP had significantly better and VP tended to have better pain reduction compared with NSM. BKP tended to have better height restoration than VP. Additionally, BKP had significant improvements in pain reduction and disability score as compared with VAI.
Clinical relevance: This meta-analysis serves to further define and support the safety and efficacy of vertebral augmentation.
Keywords: balloon kyphoplasty; meta-analysis; vertebral augmentation; vertebral compression fractures; vertebroplasty.
Conflict of interest statement
Disclosures and COI: This meta-analysis was conducted with funding from the International Society for the Advancement of Spine Surgery (ISASS); Benvenue Medical, Inc; DePuy Synthes Spine, a division of DePuy Orthopaedics, Inc; DFINE Inc; Globus Medical, Inc; Medtronic Sofamor Danek USA, Inc; and Stryker. Douglas Beall reports the following disclosures unrelated to the preparation of this manuscript: compensation, grants, and personal fees from Medtronic related to consultancy, research and teaching; grants from Benvenue, Alphatech Spine, Medical Metrics, Liventa, Vexim, and Mesoblast; consultancy fees from DEFINE and Osseon; other from Lilly, Smith & Nephew, Biomet, Vertiflex, Synthes, and Integral Spine Solutions. Morgan Lorio reports the following disclosures unrelated to the preparation of this manuscript: royalties from Choice Spine Thunderbolt, stock ownership in Orthogenerex, stock options with OrthoKinematics, intellectual property with Transformer Spine, investigator for Acadia Facet IDE Trial. B. Min Yun and Maria J. Runa are employees of Exponent, a scientific and engineering consulting firm. They have no other disclosures. Kevin Ong reports the following disclosures: employee and shareholder of Exponent, a scientific and engineering consulting firm. Exponent has been paid fees by entities in the biomedical arena for consulting services, including Zimmer Biomet, Stryker Orthopaedics, Joerns Healthcare, Ossur, DJO, Ethicon, Ferring Pharmaceuticals, Pacira Pharmaceuticals, Paradigm Spine, and Medtronic. Christopher B. Warner reports no disclosures.
Figures















Similar articles
-
Comparing effects of kyphoplasty, vertebroplasty, and non-surgical management in a systematic review of randomized and non-randomized controlled studies.Eur Spine J. 2012 Sep;21(9):1826-43. doi: 10.1007/s00586-012-2314-z. Epub 2012 Apr 29. Eur Spine J. 2012. PMID: 22543412 Free PMC article.
-
Vertebral augmentation reduces the 12-month mortality and morbidity in patients with osteoporotic vertebral compression fractures.Eur Radiol. 2021 Nov;31(11):8246-8255. doi: 10.1007/s00330-021-07985-9. Epub 2021 Apr 26. Eur Radiol. 2021. PMID: 33899142
-
A randomized trial of balloon kyphoplasty and nonsurgical management for treating acute vertebral compression fractures: vertebral body kyphosis correction and surgical parameters.Spine (Phila Pa 1976). 2013 May 20;38(12):971-83. doi: 10.1097/BRS.0b013e31828e8e22. Spine (Phila Pa 1976). 2013. PMID: 23446769 Free PMC article. Clinical Trial.
-
A prospective, international, randomized, noninferiority study comparing an implantable titanium vertebral augmentation device versus balloon kyphoplasty in the reduction of vertebral compression fractures (SAKOS study).Spine J. 2019 Nov;19(11):1782-1795. doi: 10.1016/j.spinee.2019.07.009. Epub 2019 Jul 17. Spine J. 2019. PMID: 31325625 Clinical Trial.
-
Balloon kyphoplasty and vertebroplasty in the management of vertebral compression fractures.Osteoporos Int. 2011 Dec;22(12):2915-34. doi: 10.1007/s00198-011-1639-5. Epub 2011 Jul 26. Osteoporos Int. 2011. PMID: 21789685 Review.
Cited by
-
Effect of bone cement distribution on adjacent disc degeneration after vertebral augmentation for osteoporotic vertebral compression fractures in aging patients.Front Surg. 2023 Sep 1;10:1256401. doi: 10.3389/fsurg.2023.1256401. eCollection 2023. Front Surg. 2023. PMID: 37719887 Free PMC article.
-
Utilization of Vertebral Augmentation Procedures in the USA: a Comparative Analysis in Medicare Fee-for-Service Population Pre- and Post-2009 Trials.Curr Pain Headache Rep. 2020 Apr 14;24(5):22. doi: 10.1007/s11916-020-00850-2. Curr Pain Headache Rep. 2020. PMID: 32291587 Review.
-
Osteoporotic vertebral fractures and subsequent fractures: risk factors from a retrospective observational study of patients with osteoporosis.Front Mol Biosci. 2025 Mar 19;12:1558052. doi: 10.3389/fmolb.2025.1558052. eCollection 2025. Front Mol Biosci. 2025. PMID: 40177521 Free PMC article.
-
A novel multimodal approach to C2 vertebroplasty in the setting of osteolytic metastases: A case report.Radiol Case Rep. 2025 Jun 4;20(9):4196-4202. doi: 10.1016/j.radcr.2025.05.042. eCollection 2025 Sep. Radiol Case Rep. 2025. PMID: 40528910 Free PMC article.
-
Multidisciplinary and Coordinated Management of Osteoporotic Vertebral Compression Fractures: Current State of the Art.J Clin Med. 2024 Feb 6;13(4):930. doi: 10.3390/jcm13040930. J Clin Med. 2024. PMID: 38398244 Free PMC article. Review.
References
-
- Barr JD, Barr MS, Lemley TJ, McCann RM. Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine (Phila Pa 1976) 2000;25(8):923–928. - PubMed
-
- Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348(9041):1535–1541. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous